Page results
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
This page explains what vaginal dilation therapy is and includes a step-by-step guide to how it should be performed. If you have any questions, please talk to your healthcare team.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG and topotecan (MATIN) treatment.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to a part of the brain. This page breaks down the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page is for parents and carers whose child is having radiotherapy treatment to the chest, or mediastinum.
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen and pelvis.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the testes.
File results
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023
-
FOI/2024/0179 - Water usage/ procurement
-
FOI/2024/0183 - Immunology Hidradenitis Suppurativa (HS) treatment
-
FOI/2024/0184 - IT spend/ Healthcare Information and Management Systems Society (HIMSS) EMRAM and INFRAM scores